10 completed, 1 recruiting, 1 terminated. 5 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Steatorrhea: new trials by email Literature Review of Steatorrhea trials Research Report on Steatorrhea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation Fecal Fat - Exocrine Pancreatic Insuficiency | Recruiting | Digestive Care, Inc. | 30 | 2026-08-03 | 2026-10-27 | |
| Effect of Potato Fiber on Appetite and Fecal Fat Excretion FiberBind, RG-I fiber, Placebo - Fecal Fat Increased, Obesity | Not applicable | Completed | University of Copenhagen | 18 | 2016-09-01 | 2017-09-13 |
| The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms" Cancer | Completed | Royal Marsden NHS Foundation Trust | 248 | 2014-04-01 | 2017-11-22 | |
| Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Panzytrat® 25,000, Kreon® 25,000 - Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 4 | Completed | Forest Laboratories | 87 | 2011-04-01 | 2014-04-10 |
| Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) Ultrase® MT12 - Cystic Fibrosis, Pancreatic Insufficiency | Phase 3 | Completed | Forest Laboratories | 49 | 2009-04-01 | 2017-03-16 |
| Creon in HIV Patients With Steatorrhea Creon 25000, Placebo - Steatorrhea | Phase 3 | Terminated | Abbott | 34 | 2009-01-01 | 2011-08-01 |
| Tolerance and Digestibility of a New Formula in Healthy Infants dairy lipids and soluble milk proteins - Steatorrhea, Growth | Phase 2 | Completed | Lactalis | 100 | 2008-11-01 | 2011-01-26 |
| A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency Pancrease MT 10.5, or MT 21, Placebo for Pancrease MT 10.5 or MT 21 - Exocrine Pancreatic Insufficiency, Steatorrhea | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 40 | 2008-08-01 | 2014-05-09 |
| A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) Ensure Plus, Pancrelipase in combination with Ensure Plus - Exocrine Pancreatic Insufficiency, Pancreatitis, Chronic | Phase 1 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 13 | 2008-07-01 | 2011-05-19 |
| Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) Ultrase® MT20 - Cystic Fibrosis, Pancreatic Insufficiency | Phase 3 | Completed | Forest Laboratories | 9 | 2007-07-01 | 2017-03-16 |
| Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis PANCRECARB® (pancrelipase), Placebo - Cystic Fibrosis, Pancreatic Insufficiency | Phase 3 | Completed | Digestive Care, Inc. | 29 | 2007-01-01 | 2012-02-22 |
| An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption Pancrelipase microtablets - Cystic Fibrosis, Steatorrhea | Phase 2 | Completed | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 18 | 2005-07-01 | 2011-05-19 |
Exocrine Pancreatic Insufficiency (9) · Cystic Fibrosis (6) · Malabsorption Syndromes (2) · Abdominal Pain (1) · Alagille Syndrome (1) · Anorexia (1) · Cerebral Palsy (1) · Constipation (1) · Deglutition Disorders (1) · Diarrhea (1) · Flatulence (1) · Gastroesophageal Reflux (1) · Malnutrition (1) · Mucositis (1)
Digestive System Diseases (12) · Gastrointestinal Diseases (12) · Intestinal Diseases (12) · Metabolic Diseases (12) · Nutritional and Metabolic Diseases (12) · Malabsorption Syndromes (10) · Pancreatic Diseases (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Genetic Diseases, Inborn (7) · Infant, Newborn, Diseases (6) · Lung Diseases (6) · Respiratory Tract Diseases (6) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (3) · Body Weight (2)
Pancrelipase (2) · Ensure Plus (1) · MT 21 (1)
Forest Laboratories (3) · Digestive Care, Inc. (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Abbott (1) · Lactalis (1) · McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. (1) · Royal Marsden NHS Foundation Trust (1) · University of Copenhagen (1)
United States (5) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Poland (1) · Romania (1) · United Kingdom (1)
Jervoise Andreyev, MBBS, Ph.D (1) · Linda Wedlake, RD MSc BSc (1) · Michael W Konstan, MD (1) · Suntje Sander, PhD (1)